INTERRELATIONSHIP BETWEEN METABOLIC RISK FACTORS IN ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION

Authors

  • Kholmatov Sh.A., Tulaboyeva G.M., Talipova Yu.Sh., Sagatova Kh.M., Kamolov B.B., Kurbunov N.B. Center for Professional Qualification Development of Medical Workers Author

Keywords:

Metabolic risk factors, ischemic heart disease, arterial hypertension, inflammation, C-reactive protein, glomerular filtration rate, creatinine, lipid profile, obesity, nephropathy

Abstract

 This study analyzed the correlation between metabolic risk factors in elderly patients with comorbid conditions — ischemic heart disease (IHD) and arterial hypertension (AH). The investigation compared biochemical parameters such as blood glucose, lipid profile, C-reactive protein (CRP), nitrogenous metabolites (urea, creatinine), and glomerular filtration rate (GFR) between two patient groups. The findings demonstrated stronger correlations and earlier manifestations of inflammation and renal dysfunction in patients with both IHD and AH. These results highlight the clinical importance of early detection and comprehensive monitoring of metabolic and renal indicators in elderly comorbid patients to prevent cardiovascular complications.

References

1.World Health Organization (WHO). Cardiovascular diseases (CVDs). 2023. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

2.Arnett DK, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019;140(11):e596–e646.

3.Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2022;116(1):3–12.

4.Yusuf S, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD study. Lancet. 2020;396(10258):1204–1222.

5.KDIGO 2021. Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. https://kdigo.org

6.ESC/ESH Guidelines for the Management of Arterial Hypertension. Eur Heart J. 2023.

7.Маматова Н.М. Артериал гипертония ва метаболик синдром: клиник таҳлил. Ўзбекистон тиббиёти журнали. 2023;2(10):45–50.

8.Зоиров Ф.Ф. Юрак-қон томир касалликларида биомаркерлар аҳамияти. Тиббиётда инновациялар. 2024;3(1):23–28.

Downloads

Published

2026-05-17